Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;150(1):15-20.
doi: 10.1016/j.schres.2013.04.027. Epub 2013 May 22.

Logic and Justification for Dimensional Assessment of Symptoms and Related Clinical Phenomena in Psychosis: Relevance to DSM-5


Logic and Justification for Dimensional Assessment of Symptoms and Related Clinical Phenomena in Psychosis: Relevance to DSM-5

Deanna M Barch et al. Schizophr Res. .


Work on the causes and treatment of schizophrenia and other psychotic disorders has long recognized the heterogeneity of the symptoms that can be displayed by individuals with these illnesses. Further, researchers have increasingly emphasized the ways in which the severity of different symptoms of this illness can vary across individuals, and have provided evidence that the severity of such symptoms can predict other important aspects of the illness, such as the degree of cognitive and/or neurobiological deficits. Additionally, research has increasingly emphasized that the boundaries between nosological entities may not be categorical and that the comorbidity of disorders may reflect impairments in common dimensions of genetic variation, human behavior and neurobiological function. As such, it is critical to focus on a dimensional approach to the assessment of symptoms and clinically relevant phenomena in psychosis, so as to increase attention to and understanding of the causes and consequences of such variation. In the current article, we review the logic and justification for including dimensional assessment of clinical symptoms in the evaluation of psychosis in the Fifth Edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM-5).

Keywords: Cognition; DSM-5; Diagnosis; Dimensions; Psychosis; Schizoaffective.

Similar articles

  • Structure of the psychotic disorders classification in DSM-5.
    Heckers S, Barch DM, Bustillo J, Gaebel W, Gur R, Malaspina D, Owen MJ, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W. Heckers S, et al. Schizophr Res. 2013 Oct;150(1):11-4. doi: 10.1016/j.schres.2013.04.039. Epub 2013 May 23. Schizophr Res. 2013. PMID: 23707641 Review.
  • Schizoaffective Disorder in the DSM-5.
    Malaspina D, Owen MJ, Heckers S, Tandon R, Bustillo J, Schultz S, Barch DM, Gaebel W, Gur RE, Tsuang M, Van Os J, Carpenter W. Malaspina D, et al. Schizophr Res. 2013 Oct;150(1):21-5. doi: 10.1016/j.schres.2013.04.026. Epub 2013 May 23. Schizophr Res. 2013. PMID: 23707642
  • Psychotic disorders in DSM-5: summary of changes.
    Carpenter WT, Tandon R. Carpenter WT, et al. Asian J Psychiatr. 2013 Jun;6(3):266-8. doi: 10.1016/j.ajp.2013.04.001. Epub 2013 Apr 19. Asian J Psychiatr. 2013. PMID: 23642992
  • [The schizophrenia spectrum and other psychotic disorders in the DSM-5].
    Tan N, van Os J. Tan N, et al. Tijdschr Psychiatr. 2014;56(3):167-72. Tijdschr Psychiatr. 2014. PMID: 24643825 Review. Dutch.
  • Psychosis.
    Arciniegas DB. Arciniegas DB. Continuum (Minneap Minn). 2015 Jun;21(3 Behavioral Neurology and Neuropsychiatry):715-36. doi: 10.1212/01.CON.0000466662.89908.e7. Continuum (Minneap Minn). 2015. PMID: 26039850 Free PMC article. Review.
See all similar articles

Cited by 32 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources